Skip to main content
. Author manuscript; available in PMC: 2026 Mar 10.
Published in final edited form as: Cancer Cell. 2025 Feb 27;43(3):552–562.e9. doi: 10.1016/j.ccell.2025.02.004

Figure 2: GT5 T cells are highly glycolytic in vitro.

Figure 2:

A) Schematic for the experiments below.

B) NMR spectroscopy analysis of extracellular [2-13C] lactate, produced by OT-I cells following a 4h incubation with [2-13C] glucose or [2-13C] fructose alone. Peak areas were used for measuring concentrations. Mean lactate concentrations ± SEM shown (n=3, two-tailed Student’s T test).

C) NMR spectroscopy analysis of extracellular 13C lactate, produced by OT-I cells, following a 4h incubation with [2-13C] glucose plus unlabeled fructose or with [2-13C] fructose plus unlabeled glucose. Analysis as in B). (n=3, two-tailed Student’s T test).

D) Heatmap of LC-MS derived fractional enrichment of indicated intracellular metabolites in OT-I cells following a 4h incubation with [U-13C] glucose plus unlabeled fructose or with [U-13C] fructose plus unlabeled glucose; bold text indicates isotopic. Gradient of blue shading represents the magnitude of fractional enrichment.

E) Fractional enrichment of representative metabolites as in D). n=3, one-way ANOVA.

F) Same as in B) but in 19BBz CAR T cells. n=3, two-tailed Student’s T test.

G) Same as in C) but in 19BBz CAR T cells. n=3, two-tailed Student’s T test.

*, p < 0.05; **, p < 0.01; ***, p < 0.001.

See also Figure S3.